comparemela.com

Latest Breaking News On - Cardiovascular business development - Page 1 : comparemela.com

Cardiosense Begins Enrollment in Nationwide Heart Failure Study

MCRA Aids Surmodics in Obtaining FDA Pre-Market Approval for Cardiovascular Drug-Coated Balloon

Cambrian Biopharma: Cambrian Bio launches Amplifier Therapeutics to develop clinical-stage AMPK activator

MCRA Expands its Cardiovascular Division, Hiring Fernando Aguel, Former Assistant Division Director, FDA Circulatory Support Devices

MCRA Expands its Cardiovascular Division, Hiring Fernando Aguel, Former Assistant Division Director, FDA Circulatory Support Devices News provided by Share this article Share this article WASHINGTON, May 20, 2021 /PRNewswire/ MCRA, LLC, a leading medical device and biologics advisory firm and clinical research organization (CRO) integrating US and International Regulatory, Clinical Research, Reimbursement, Healthcare Compliance, and Quality Assurance, is pleased to announce the hiring of Fernando Aguel as Vice President, Heart Failure & Circulatory Support Regulatory Affairs. Fernando previously served as U.S. Food and Drug Administration (FDA) Assistant Division Director, Circulatory Support Devices Team. MCRA s Cardio division continues to expand its expertise across all product areas in the cardiovascular space to provide clients with expert regulatory guidance, clinical study design and clinical trial execution. 

MCRA Hires Cardiovascular Industry Leader Dr Hans-Peter Stoll to its CRO Management Team

Share this article Share this article WASHINGTON, March 11, 2021 /PRNewswire/ MCRA, LLC, a leading medical device and biologics advisory firm and clinical research organization (CRO) dedicated to integrating US and International Regulatory, Clinical Research, Reimbursement, Healthcare Compliance, and Quality Assurance, is pleased to announce the hiring of Dr. Hans-Peter Stoll, an interventional cardiologist. Dr. Stoll formerly served as Chief Medical Officer at Biosensors International where he led the clinical affairs group and provided medical strategic leadership to executive management. Additional cardiovascular device industry experience includes roles as Chief Medical Officer Cardiology at GE Healthcare and as Worldwide Vice President Clinical Research at Cordis, a Johnson & Johnson company.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.